medigraphic.com
ISSN 1561-302X (Print)

2023, Number 1

<< Back Next >>

Rev cubana med 2023; 62 (1)

Common risk factors for cardiovascular disease and their predictive value in the elderly

Hierrezuelo RN, del Rio CG, Hernández MA

Language: Spanish
References: 39
Page: 1-12
PDF size: 332.66 Kb.


ABSTRACT

Introduction: In old age, the predictive value of common risk factors is inconsistent. With increasing age, the associations between common risk factors and cardiovascular disease change.
Objective: To collect information on the common risk factors for cardiovascular disease and their predictive value in the elderly.
Methods: A review on this subject was carried out at Ramón López Peña community clinic in Santiago de Cuba, from January to May 2022. The search was carried out from Pubmed, Infomed and SciELO databases, with no date restrictions, in Spanish and English.
Results: The most recent findings suggest that common risk factors for cardiovascular disease might be weaker predictors of future risk in the elderly, while the strength of other factors increases with age. Older people constitute a special subgroup in which other factors such as polypharmacy, orthostatic hypotension, depression, and physical condition have been shown to be potentially important determinants of their cardiovascular risk.
Conclusions: The predictive value of blood pressure, cholesterol and obesity in the elderly decreases or even reverses, while others such as polypharmacy, frailty and cognitive impairment appear to be promising.


REFERENCES

  1. Paramio A, Aguilera García L, Carrazana Garcés E, Hernández Navas M. Riesgo cardiovascular global en tres casas de abuelos del municipio Boyeros. Rev. Cuban. de Med. Gen. Int. 2021 [acceso: 21/01/2022];37(4):1-16. Disponible en: http://www.revmgi.sld.cu/index.php/mgi/article/view/14171.

  2. Neumann JT, Thao LTP, Callander E, Chowdhury E, Williamson JD, Nelson MR, et al. Cardiovascular risk prediction in healthy older people. Geroscience. 2022 [acceso: 26/01/2022];44(1):403-413. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810999/2.

  3. Ministerio de Salud Pública. Dirección nacional de registros médicos y estadísticas de salud. Anuario estadístico. 2020 [acceso: 25/01/2022]. Disponible en: https://temas.sld.cu/.../2021/08/11/anuario-estadistico-de-salud-20203.

  4. Pérez MD, León JL, Dueñas A, Alfonzo JP, Navarro DA, de la Noval R, et al. Guía cubana de Diagnóstico, Evaluación y Tratamiento de la Hipertensión Arterial. Rev Cuban Med. 2017 [acceso: 27/01/2022];56(4):242-321 Disponible en www.scielo.sld.cu/pdf/med/v56n4/med01417.pdf [ Links ]

  5. Dalton JE, Rothberg MB, Dawson NV, Krieger NI, Zidar DA, Perzynski AT. Failure of traditional risk factors to adequately predict cardiovascular events in older populations. J Am Geriatr Soc. 2020 [acceso: 25/01/2022];68(4):754-61. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31958154/5.

  6. Gabriel R, Muñiz J, Vega S, Moral I, Pérez TR, Rodríguez F, et al. Riesgo cardiovascular en la población anciana española. Escala de riesgo EPICARDIAN. Rev. Clín Español. 2022 [acceso: 21/02/2022];222(1):13-21. Disponible en: https://www.researchgate.net/publication/353214375c=publicationCoverPdf6.

  7. Uthman OA, Hartley L, Rees K, Taylor F, Ebrahim S, Clarke A. Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries. Cochrane Database Syst Rev. 2015 [acceso: 29/01/2022];2015(8):1-67. Disponible en: https://onlinetools.sodapdf.com/document/0ae08bad-d64c-4a9d-8c54-28d8095eebc37.

  8. Mondeja JR, Chavez E, Puerto M, Blay L, Cápiro LR. Escala de riesgo y estratificación pronóstica de la cardiopatía isquémica en población adulta. VIII Jornada conmemorativa de ciencias cardioquirúrgicas Dr. Ismael Alejo in memoriam. 2021. [acceso: 20/02/2022]. Disponible en: https://alejoinmemoriam2021.sld.cu/index.php/alejoinmemoriam/ai2021/paper/viewFile/84/278.

  9. Gil E. Factores de riesgo vascular. En: Melero M, Arfeliz N,Girbaut M, editores. Medicina Interna.T.2. 18a ed. Barcelona, España: Editorial ELSEVIER; 2016. p. 478. [acceso: 28/01/2022]. Disponible en:https://archive.org/stream/farreras-rozman-medicina-interna-18a edicion/Farreras%20Rozman%20Medicina%20Interna%2018a%20Edicion_djvu.txt9. : [ Links ]

  10. Díaz A, Rodríguez A, García R, Carbonell I, Achiong F. Resultados de una intervención para la mejora del control de la hipertensión arterial en cuatro áreas de salud. Rev. Finlay. 2018 [acceso: 29/01/2022];8(3):180-9. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S222 1-24342018000300002&lng=es10.

  11. Dyakova M, Shantikumar S, Colquitt JL, Drew C, Sime M, MacIver J, et al. Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2016. [acceso: 27/02/2022];(1):CD010411. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6494380/11.

  12. Visseren F, Mach F, Smulders Y. Guidelines on cardiovascular disease prevention in clinical practice. 2021 [acceso: 11/03/2022];42(34):3227-337. Disponible en: https://academic.oup.com/eurheartj/article/42/34/3227/6358713?login=false12.

  13. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics-2016. A report from the American Heart Association. Circulation. 2016 [acceso: 24/02/2022];133(4):e38-360. Disponible en: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000350?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed13.

  14. Rich MW, Chyun DA, Skolnick AH, Alexander KP, Forman DE, Kitzman DW et al. Knowledge Gaps in Cardiovascular Care of the Older Adult Population. Circulation. 2016 [acceso: 09/03/2022];133(21):2103-22. Disponible en: https://www.ahajournals.org/doi/10.1161/CIR.0000000000000380?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed14.

  15. Sociedad Europea de Cardiología. Guía ESC 2016 sobre prevención de la enfermedad cardiovascular en la práctica clínica. Rev. Español de Cardiol.2016. [acceso: 09/04/2022];69(10):939e1-39.e87. Disponible en: https://www.revespcardiol.org/es-guia-esc-2016-sobre-prevencion-articulo-S030089321630414615.

  16. Van EF, Hoevenaar MP, Pobretvliet RKE, Gussekloo J, Van JV, Van WA. Predictive value of traditional risk factors for cardiovascular disease in older people: A systematic review. Preventive Med. 2020 [acceso: 12/04/2022];132:105986. Disponible en: https://www.sciencedirect.com/science/article/pii/S0091743520300104?via%3Dihub16.

  17. Simons LA, Simons J, Friedlander Y, McCallum J, Palaniappan L. Risk functions for prediction of cardiovascular disease in elderly Australians: the Dubbo Study. Med J Aust. 2003 [acceso: 09/04/2022];178(3):113-6.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3133925/17.

  18. Satish S, Freeman DH Jr, Ray L, Goodwin JS. La relación entre la presión arterial y la mortalidad en los ancianos más viejos. J Am Geriatr Soc. 2001;49(4):367-74. DOI: https://agsjournals.onlinelibrary.wiley.com/doi/abs/10.1046/j.1532-5415.2001.49078.x?sid=nlm%3Apubmed18.

  19. Odden MC, Peralta CA, Haan MN, Covinsky KE. Rethinking the association of high blood pressure with mortality in elderly adults: The impact of frailty. Arch Intern Med. 2012 [acceso: 11/04/2022];172(15):1162-8. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537835/19.

  20. Liang Y, Vetrano DL, Qiu C. Colesterol total sérico y riesgo de mortalidad cardiovascular y no cardiovascular en la vejez: un estudio poblacional. BMC Geriatr. 2017 [acceso: 11/04/2022];17(1):294. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745647/20.

  21. Cedeño S, Goicoechea M, Torres E, Verdalles Ú, Pérez A, Verde E, et al. Predicción del riesgo cardiovascular en pacientes con enfermedad renal crónica. Nefrol (Madr.). 2017;37(3):293-300. DOI: https://dx.doi.org/10.1016/j.nefro.2016.10.00221. . [ Links ]

  22. Sperrin M, Martin GP, Pate A, Van T, Peek N, Buchan I. Using marginal structural models to adjust for treatment drop-in when developing clinical prediction models. Stat. Med. 2018 [acceso: 01/04/2022];37(28):4142-54. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282523/22.

  23. Ahmadi SF, Streja E, Zahmatkesh G, Streja D, Kashyap M, Moradi H, et al. Reverse epidemiology of traditional cardiovascular risk factors in the geriatric population. J. Am. Med. Dir. Assoc. 2015 [acceso: 04/04/2022];16(11):933-9. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636955/23.

  24. Lind L, Sundstrom J, Arnlov J, Lampa E. Impact of aging on the strength of cardiovascular risk factors: a longitudinal study over 40 years. J. Am. Heart Assoc. 2018 [acceso: 02/03/2022];7(1):e007061. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778963/24.

  25. Jansen J, McKinn S, Bonner C, Irwig L, Doust J, Glasziou P, et al. Systematic review of clinical practice guidelines recommendations about primary cardiovascular disease prevention for older adults. BMC Fam. Pract. 2015 [acceso: 16/04/2022];16(104). Disponible en: https://bmcprimcare.biomedcentral.com/articles/10.1186/s12875-015-0310-125.

  26. Veronese N, Cereda E, Stubbs B, Solmi M, Luchini C, Manzato E,et al. Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: results from a meta-analysis and exploratory metaregression analysis. Ageing Res. Rev. 2017 [acceso: 04/04/2022];35,63-73. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047747/26.

  27. Mitchell JD, Fergestrom N, Gage BF, Paisley R, Moon P, Novak E, et al. Impact of statins on cardiovascular outcomes following coronary artery calcium scoring. J. Am. Coll. Cardiol. 2018 [acceso: 09/03/2022];72(25):3233-42.Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6309473/27.

  28. Dalton JE, Rothberg MB, Dawson NV, Krieger NI, Zidar DA, Perzynski AT. Failure of traditional risk factors to adequately predict cardiovascular events in older populations. AGS. 2020. [acceso: [16/03/2022];68(4):754-61. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156319/28.

  29. Eurelings LS, Van JW, Ter G, Mol CHEP, Richard E, Van W. Apathy and depressive symptoms in older people and incident myocardial infarction, stroke, and mortality: a systematic review and meta-analysis of individual participant data. Clin Epidemiol. 2018 [acceso 26/04/2022];10:363-79. Disponible en: https://www.dovepress.com/apathy-and-depressive-symptoms-in-older-people-and-incident-myocardial-peer-reviewed-fulltext-article-CLEP29.

  30. Xu M, Zhao J, Zhang Yu, Ma X, Dai Q, Zhi H, et al. Apolipoprotein E gene variants and risk of coronary heart disease: a meta-analysis. Biomed Res Int. 2016 [acceso 27/03/2022];2016:3912175. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102878/30.

  31. Benetos A, Petrovic M, Strandberg T. Hypertension management in older and frail older patients. Circ Res. 2019;124(7):1045-60.DOI: https://www.ahajournals.org/doi/full/10.1161/CIRCRESAHA.118.313236? [ Links ]

  32. Benetos A, Bulpitt CJ, Petrovic M, Ungar A, Rosei EA, QuerubinÍn A, et al. An expert opinion from the European society of hypertension-European Union Geriatric Medicine Society Working Group on the Management of Hypertension in very old, Frail Subjects. Hypertension. 2016;67(5):820-5. DOI: https://www.ahajournals.org/doi/10.1161/HYPERTENSIONAHA.115.07020?32.

  33. Triantafyllou A, Douma E. Evaluación del riesgo cardiovascular en ancianos sin enfermedad ECV manifiesta. ¿Podrían los factores de riesgo tradicionales encajar en todas las edades? JCH. 2019;21(8):1153-4. DOI: https://onlinelibrary.wiley.com/doi/full/10.1111/jch.1361633.

  34. Benetos A, Labat C, Rossignol P, Renaud F, Rolland Y, Valvusa F, et al. Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents: the PARTAGE study. JAMA Intern Med. 2015 [acceso 02/04/2022];175(6):989-995.Disponible en: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2110995#15138948834.

  35. Fried LP, Kronmal RA, Newman AB, Bild DE, Mittelmark MB, Polak JF, et al. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA. 1998 [acceso 17/03/2022];279(8):585-92.Disponible en: https://jamanetwork.com/journals/jama/fullarticle/18727735.

  36. Rodondi N, Locatelli I, Aujesky D, Butler J, Vittinghoff E, Simonsick E, et al. Framingham risk score and alternatives for prediction of coronary heart disease in older adults. PLoS ONE. 2012 [acceso: 28/02/2022];7(3):e34287. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314613/36.

  37. Wong TY, Massa MS, O'Halloran AM, Kenny RA, Clarke R. Cardiovascular risk factors and frailty in a cross-sectional study of older people: implications for prevention. Envejecimiento. 2018 [acceso 27/03/2022]1;47(5):714-20. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108388/37.

  38. Stewart RAH, Held C, Krug S, Waterworth D, Stebbins A, ChiswellK, et al. Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease. JAMA. 2019. [acceso: 17/03/2022];8(7):e010641. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509727/38.

  39. Martínez FM, Bou MM, Pilar P, Gollarted FG. Prevalencia de patología cardiovascular y polifarmacia en ancianos que viven en residencias en la comunidad Valenciana. THERAPEÍA 8. 2016 [acceso: 28/03/2022]:19-29. Disponible en: https://riucv.ucv.es/bitstream/handle/20.500.12466/296/Therapeia%208-1.pdf?sequence=1&isAllowed=y 1.pdf?sequence=1&isAllowed=y39.




2020     |     www.medigraphic.com